tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GILD Stock Latest News

Assembly Biosciences announces $30.1M investment, funding from Gilead
The FlyAssembly Biosciences announces $30.1M investment, funding from Gilead
2d ago
ASMB
GILD
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe Fly
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
2d ago
CAPR
GILD
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
PremiumThe Fly
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
4d ago
GILD
Gilead, Terray Therapeutics announce research collaboration
PremiumThe Fly
Gilead, Terray Therapeutics announce research collaboration
4d ago
GILD
Gilead announces positive CHMP opinion for seladelpar
PremiumThe Fly
Gilead announces positive CHMP opinion for seladelpar
8d ago
GILD
Gilead appoints Dietmar Berger as Chief Medical Officer
PremiumThe FlyGilead appoints Dietmar Berger as Chief Medical Officer
9d ago
GILD
eBay downgraded, GM upgraded: Wall Street’s top analyst calls
Premium
The Fly
eBay downgraded, GM upgraded: Wall Street’s top analyst calls
11d ago
T
GM
Gilead reinstated with a Buy at BofA
Premium
The Fly
Gilead reinstated with a Buy at BofA
11d ago
GILD
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
PremiumThe Fly
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
12d ago
GILD
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
PremiumThe Fly
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
12d ago
GILD
Gilead price target raised to $115 from $105 at Oppenheimer
PremiumThe Fly
Gilead price target raised to $115 from $105 at Oppenheimer
12d ago
JNJ
ACLX
Arcellx, Gilead announce new data from iMMagine-1 study of anitocabtagene autole
PremiumThe Fly
Arcellx, Gilead announce new data from iMMagine-1 study of anitocabtagene autole
12d ago
ACLX
GILD
Gilead enters ADC option and license pact with Tubulis, sees dilution
PremiumThe FlyGilead enters ADC option and license pact with Tubulis, sees dilution
18d ago
GILD
Gilead announces PURPOSE 2 trial data published in NEJM
Premium
The Fly
Gilead announces PURPOSE 2 trial data published in NEJM
24d ago
GILD
Gilead price target raised to $96 from $70 at UBS
Premium
The Fly
Gilead price target raised to $96 from $70 at UBS
30d ago
GILD
Gilead price target raised to $100 from $90 at Mizuho
PremiumThe Fly
Gilead price target raised to $100 from $90 at Mizuho
1M ago
GILD
Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
PremiumThe Fly
Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
1M ago
GILD
HOOK
Gilead price target raised to $100 from $85 at Argus
PremiumThe Fly
Gilead price target raised to $100 from $85 at Argus
1M ago
GILD
Gilead price target raised to $84 from $81 at RBC Capital
PremiumThe Fly
Gilead price target raised to $84 from $81 at RBC Capital
1M ago
GILD
Ideaya Biosciences appoints Stu Dorman as chief commercial officer
PremiumThe FlyIdeaya Biosciences appoints Stu Dorman as chief commercial officer
1M ago
GILD
IDYA
Gilead announces data from interim analysis of Phase 3 ASSURE study
Premium
The Fly
Gilead announces data from interim analysis of Phase 3 ASSURE study
1M ago
GILD
Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
Premium
The Fly
Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
1M ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >